Pioneering amfAR-Funded Study Underway

A potentially groundbreaking clinical trial will test a combination HIV cure strategy.

• The Past, Present, and Future of HIV Reservoir Cells
• HIV Reservoirs in the Blood and Gut Respond Differently to Virus Activators
• Launching an HIV Trial in the Time of COVID-19
• A Tale of Two Viruses: HIV Researcher Joins Fight Against COVID-19

amfAR Study Shows How White Counties Have Lower Rates of COVID-19, HIV

Study shows that primarily white counties in the U.S. have the fewest cases of COVID-19 irrespective of geographic region, political inclination or before/after re-opening the economy.

• amfAR Study Shows Disproportionate Impact of COVID-19 on Black Americans
• Victory for AIDS Activists over Vaccine Trial Exclusion
• Context Matters - Health Insurance Coverage Is Fundamental to Ending the HIV Epidemic

ISSUE BRIEF: Violence Crisis Services During Lockdown

amfAR assesses GBV service availability during COVID-19 lockdown in South Africa.

• Global Anti-HIV Drug Supplies Running Low
• COVID-19 Pandemic Threatens HIV Drug Supplies
• Former TREAT Asia Student Researcher Named Student Who Rocked Public Health

Knowledge Is Power: Helping Latinos Fight HIV

For National Latinx AIDS Awareness Day on October 15, we spoke with Hector Hugo Gonzalez about the challenges and way forward for Latinos combating HIV.

COVID-19 and HIV/AIDS

We are constantly gathering new information to keep you up to date on the intersection between HIV and COVID-19. The hard-won lessons of HIV research are informing the race to find effective treatments and a vaccine for COVID-19.

Intersections #8: HIV and COVID-19 – DNA Vaccine

amfAR-funded HIV researcher Dr. Dan Barouch of Harvard Medical School talks to amfAR’s Dr. Rowena Johnston about his team’s efforts to rapidly develop a safe and effective vaccine against the coronavirus.